E. Antman, D. Anbe, P. Armstrong, E. Bates, L. Green et al., AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology, American Heart Association

R. Mehta, F. Ou, E. Peterson, R. Shaw, W. Hillegass et al., Clinical Significance of Post-Procedural TIMI Flow in Patients With Cardiogenic Shock Undergoing Primary Percutaneous Coronary Intervention, JACC: Cardiovascular Interventions, vol.2, issue.1
DOI : 10.1016/j.jcin.2008.10.006

D. Holmes, . Jr, R. Califf, F. Van-de-werf, P. Berger et al., Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial, The Lancet, vol.349, issue.9045, pp.75-83, 1997.
DOI : 10.1016/S0140-6736(96)03031-0

H. Dauerman, R. Goldberg, K. White, J. Gore, I. Sadiq et al., Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock, The American Journal of Cardiology, vol.90, issue.8
DOI : 10.1016/S0002-9149(02)02704-2

R. Huang, J. Sacks, H. Thai, S. Goldman, D. Morrison et al., Impact of stents and abciximab on survival from cardiogenic shock treated with percutaneous coronary intervention, Catheterization and Cardiovascular Interventions, vol.39, issue.1
DOI : 10.1161/01.CIR.98.8.734

U. Zeymer, U. Tebbe, M. Weber, H. Vohringer, R. Jaksch et al., Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial

A. Chan, D. Chew, D. Bhatt, D. Moliterno, E. Topol et al., Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction, The American Journal of Cardiology, vol.89, issue.2
DOI : 10.1016/S0002-9149(01)02188-9

A. Samadi, L. Feuvre, C. Allali, Y. Collet, J. Barthelemy et al., Medium-term survival after primary angioplasty for myocardial infarction complicated by cardiogenic shock after the age of 75 years, Archives of Cardiovascular Diseases, vol.101, issue.3
DOI : 10.1016/S1875-2136(08)71800-X

G. Marenzi, M. Moltrasio, E. Assanelli, G. Lauri, I. Marana et al., Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty, American Heart Journal, vol.153, issue.5
DOI : 10.1016/j.ahj.2007.02.018

C. Torgersen, C. Schmittinger, S. Wagner, H. Ulmer, J. Takala et al., Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study, Critical Care, vol.13, issue.5, p.157, 2009.
DOI : 10.1186/cc8114

S. Valente, C. Lazzeri, S. Vecchio, C. Giglioli, M. Margheri et al., Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock, International Journal of Cardiology, vol.114, issue.2
DOI : 10.1016/j.ijcard.2006.01.024

W. Schreiber, H. Herkner, M. Koreny, A. Bur, M. Hirschl et al., Predictors of survival in unselected patients with acute myocardial infarction requiring continuous catecholamine support, Resuscitation, vol.55, issue.3, pp.269-76, 2002.
DOI : 10.1016/S0300-9572(02)00266-6

F. Kushner, M. Hand, S. Smith, . Jr, S. King et al., focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation, Association Task Force on Practice Guidelines, 2009.

D. Brunet, H. Eltchaninoff, M. Kerkeni, C. Tron, B. Baala et al., Mechanical circulatory assistance in myocardial infarction with refractory cardiogenic shock: clinical experience in 10 patients at a teaching hospital in Rouen, Archives of Cardiovascular Diseases, vol.101, issue.1
DOI : 10.1016/S1875-2136(08)70252-3